Back to Insider Trading View Full Company Profile

XERS

STRONG

Xeris Biopharma Holdings, Inc.

CIK: 0001867096

Strong Sell (70% confidence)

Last activity: 3 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Total Cash $111.04M
Total Debt $220.34M
Current Ratio 2.19

Insider Roster (6 total, 6 active)

Insider Buys Sells Net Value Holdings
JOHNSON JOHN
DIRECTOR
0 1 -$977K
698,083 shares
$5.04M
Hecht Beth
See Remarks
0 4 -$352K
1,226,607 shares
$7.65M
Shannon John Patrick Jr
See Remarks
0 1 -$176K
2,705,346 shares
$19.14M
McCulloch Kevin
See Remarks
0 1 -$120K
1,685,426 shares
$13.48M
BORMANN-KENNEDY BARBARA-JEAN ANNE
DIRECTOR
0 1 -$106K
142,500 shares
$1.01M
Brady James Aloysius
DIRECTOR
0 1 -$60K
89,166 shares
$494K

Recent Transactions

SELL Brady James Aloysius (DIRECTOR)

10,834 shares @ $5.54

$60K

Mar 30, 2026

Conviction: | View SEC Filing →
SELL Hecht Beth (See Remarks)

16,567 shares @ $6.24

$103K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Hecht Beth (See Remarks)

100 shares @ $7.06

$706

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Hecht Beth (See Remarks)

16,667 shares @ $7.45

$124K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL McCulloch Kevin (See Remarks)

15,000 shares @ $8.00

$120K

Jan 8, 2026

Conviction: | View SEC Filing →
SELL Shannon John Patrick Jr (See Remarks)

24,907 shares @ $7.08

$176K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Hecht Beth (See Remarks)

16,667 shares @ $7.43

$124K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL JOHNSON JOHN (DIRECTOR)

135,400 shares @ $7.22

$977K

Dec 19, 2025

Conviction: | View SEC Filing →
SELL BORMANN-KENNEDY BARBARA-JEAN ANNE (DIRECTOR)

15,000 shares @ $7.09

$106K

Dec 12, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.